2nd SEPTEMBER 2010 - SHARE INFORMATION
Since our previous announcement the company has been engaged in reviewing two further proposals that would have a significant influence on the future prospects of the business. We are trying to expedite matters as quickly as possible but we are obligated to review all proposals in detail. The match bargain facility will remain suspended but we hope that matters can be resolved as early as possible. Thank you for your patience and support.
24th - 28th MAY 2010 - BRAZIL HOSPITALAR EVENT A MAJOR SUCCESS
Biotech International Limited is pleased to announce that the exhibition was a roaring success for all concerned. Many new leads and enquiries have given Biotech, the Distributor and indeed the Governments and Commercial enterprises of many countries a reason to be very excited at the product ranges potential in the future.
Countries including Brazil, Argentina, Columbia and Chile plus several in the Central America region have all requested more informationon the product and progress forward in developing a sales opportunity. Many of these countries have enormous diease problems and face pending pandemics. They could not believe the products capabilities and were interested in discussing further.
The distributor is now working with all haste on these new leads and Biotech's sales and marketing team are supporting him in every instance and step of the way. The stand stood out from manyothers (see attached photograph) andboth Rob Hastings and Neil Riches who both speak Spanish were kept extremely busy. There will be updates as we progress with all countries.
click on picture for larger view
Stand in Brazil with Rob hastings & Neil Riches
24th MAY 2010 - BIOTECH EXHIBITS IN BRAZIL "HOSPITALAR EVENT"
Biotech International Limited is attending the UK Trade & Investment event in Sao Paulo, Brazil on 25th May 2010. This event is an exceptional opportunity for our ongoing South American business plans. With over 78,000 professional visitors to the show, Hospitalar offers an ideal stage for UK healthcare companies to showcase their innovative products to an international audience. Rob Hastings will be Biotech's representative working with our current South American distributors.
The fair is already established as the leading trading point for new technologies, representing a great opportunity for British companies to promote products and services while updating hospitals, health clinics and laboratories.The event is:
Held at Expo Center Norte, Sao Paulo, Brazil, the Hospitalar is evolved out as one of the highly reputed podium for medical suppliers, industry professionals, government bodies, hospital administrators, doctors, nurses and other health care professionals. Organized by Messe Dusseldorf GmbH, it is 4 days event which offers base for establishing contacts with leading players of the medical world.
Designated one of UKTI's High Growth Markets, Brazil is the UK's most important trading partner in Latin America, with UK exports of goods valued at £523m in 2008, an increase of 50% on 2007. Bilateral trade between Brazil and the UK increased 38% to over £4 billion last year. (Source: UK Overseas Trade Statistics, HMR&C) The UK is one of Brazil's largest foreign investors, and many large UK corporations have well-established operations in the country. There is also a growing middle class in Brazil who have real spending power and who appreciate high quality merchandise. If a product or service is generally competitive in world markets it is also likely to be so in Brazil.
The UK’s top exports include:
Power Generation Machinery
Medicinal & Pharmaceutical Products
Chemical Materials & Products
The event covers 4 days and all samples, display material has been sent to Brazil. We will update this site after the event
24th APRIL 2010 - NEW COMPANY ANOUNCEMENT
To view you need to login or register
21st December 2009 - COMPANY ANOUNCEMENT
To view you need to login login or register
15th October 2009 - PRESS ANOUNCEMENTS -
please login or register to view
5th October 2009 - New announcements
please click here to register
or login here
- you will receive an email by return with a link and login information (please make a note of the link and login details for future use)
Company announcements, press releases and news coverage
Biotech Bangladesh launch in Dhaka
TV and print media covered the launch on Saturday 31 January
of Biotech Bangladesh in Dhaka. Speakers included Prof. Dr. Abdul Hannan of
the Bangladeshi Ministry of Health and Mr. Kevin Ringham, Director of Trade
and Investment from the British High Commission in Dhaka. 
John Coombs, CEO Biotech International, said "This launch today represents the culmination of three years of hard work, both by Biotech personnel and our Bangladeshi agent Akthar Hussain, to bring our products to the Bangladesh market. I welcome the Minister's view that EnviroCair may be available to farmers and healthcare institutions within a matter of weeks. Both our products will bring much needed support in the fight against both pathogens and vector-borne diseases and can only benefit the people of Bangladesh. It is vital that the poultry sector, already hit by bird flu, is protected by EnviroCair-AV and that measures are put in place to halt the spread of this disease."
Since the H5N1 virus was first detected in Bangladesh, at a state-run poultry farm on the outskirts of the capital, authorities have culled more than two million birds, causing losses estimated at 700 million US dollars.
With 47 of Bangladesh’s 64 districts affected, the poultry industry, introduced two decades ago to help this impoverished country, is now facing its biggest ever challenge. Affected are more than 1.5 million people employed in one of the world's largest poultry industries that produces producing 220 million chickens and 37 million ducks annually.
The poultry sector supports five million people directly or indirectly through 150,000 poultry farms, constituting 1.6 percent of Bangladesh's gross domestic product (GDP).
Akthar Hussain (L) and Kenny Hossain (R) of Biotech Bangladesh Ltd with John Coombs, CEO, Biotech International |
February 2009